BioCentury
ARTICLE | Company News

Third Wave sales and marketing update

November 8, 1999 8:00 AM UTC

Third Wave launched its Factor II Invader assay that detects mutations in the Factor II (prothrombin) gene, which the company said is associated with deep vein thrombosis and pulmonary embolism. ...